Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Increasing age (per 10 years: OR, 1.71 [95% CI, 1.20 to 2.44]; p = 0.003), higher HbA1c (per 1%: OR, 1.77 [95% CI, 1.18 to 2.65]; p = 0.006), lower magnesium (per 0.1 mg/dL: OR, 0.90 [95% CI, 0.81 to 0.99]; p = 0.031), lower vitamin B12 (per 100 pg/mL: OR, 0.72 [95% CI, 0.58 to 0.88]; p = 0.003), and lower vitamin D levels (per 5 ng/mL: OR, 0.63 [95% CI, 0.51 to 0.77]; p < 0.001) were associated with CIPN EOT.
Source: Factors Associated With Moderate‐to‐Severe CIPN. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Eligible patients were ≥ 18 years of age, had no history of severe cardiovascular or peripheral vascular disease, and planned to receive six cycles of adjuvant chemotherapy after surgery or six cycles of systemic therapy for metastatic disease.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Limb Compression Therapy and Chemotherapy‐Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self‐Controlled Study(NEURO‐GLOVE Trial)
Study design awaiting verification · International Journal of Cancer · 2026
Original publication title
Limb Compression Therapy and Chemotherapy‐Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self‐Controlled Study(NEURO‐GLOVE Trial)
© 2026 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
ABSTRACT
Chemotherapy‐induced peripheral neuropathy (CIPN) is a dose‐limiting toxicity of taxane‐based chemotherapy with limited preventive options. We evaluated whether dual‐site mechanical compression during paclitaxel infusion reduces CIPN in women with gynecologic cancers. In this prospective, intraindividual, self‐controlled study, patients receiving carboplatin: paclitaxel underwent compression of the nondominant hand (two surgical gloves) and ipsilateral lower limb (Class II stocking), while contralateral limbs served as controls. CIPN was assessed using CTCAE v5.0 and EORTC QLQ‐CIPN20 at baseline, Cycle 3, end of treatment (EOT), and 3‐ and 6‐month follow‐up.
Among 76 patients (median age, 61 years), moderate‐to‐severe CIPN was observed less frequently in compression limbs than in control limbs at Cycle 3 (35.5% vs. 53.9%; p = 0.001), EOT (59.2% vs. 69.7%; p = 0.021), 3 months (28.9% vs. 52.6%; p = 0.015), and 6 months (20.3% vs. 33.8%; p = 0.002). Repeated‐measures analyzes showed significant time‐by‐limb interactions for sensory (p = 0.003), lower‐extremity sensory (p = 0.018), and motor domains (p = 0.041). Sensory CIPN20 scores were lower in compression limbs in the upper extremities from EOT onward (7.5 vs. 10.2; p < 0.001) and in the lower extremities at 3‐month (8.7 vs. 10.7; p < 0.001) and 6‐month follow‐up (7.0 vs. 10.0; p < 0.001).
EORTC QLQ‐CIPN20 sensory scores identified grade ≥ 2 neuropathy with AUC values > 0.92 at all time points. Dual‐site mechanical compression was associated with reduced incidence and persistence of CIPN. As a low‐cost and scalable intervention, this strategy may improve treatment tolerability and survivorship outcomes.
Trial Registration:
ClinicalTrials.gov identifier: NCT07105553
What's new?
With no effective drug‐based prevention strategies available for chemotherapy‐induced peripheral neuropathy (CIPN), research in neuroprotective approaches has grown. Of particular interest is mechanical compression, which may protect nerves by temporarily reducing blood flow during treatment. The authors here conducted a prospective trial in women with gynecologic cancers, applying mechanical compression to one hand and leg during treatment while using the opposite limbs as controls. Compression‐treated limbs consistently experienced lower rates and severity of neuropathy during treatment and up to six months afterward.
As a low‐cost, scalable intervention, dual‐site mechanical compression can potentially improve treatment tolerability and reduce long‐term nerve damage.
Authors’ abstract
ABSTRACT
Chemotherapy‐induced peripheral neuropathy (CIPN) is a dose‐limiting toxicity of taxane‐based chemotherapy with limited preventive options. We evaluated whether dual‐site mechanical compression during paclitaxel infusion reduces CIPN in women with gynecologic cancers. In this prospective, intraindividual, self‐controlled study, patients receiving carboplatin: paclitaxel underwent compression of the nondominant hand (two surgical gloves) and ipsilateral lower limb (Class II stocking), while contralateral limbs served as controls. CIPN was assessed using CTCAE v5.0 and EORTC QLQ‐CIPN20 at baseline, Cycle 3, end of treatment (EOT), and 3‐ and 6‐month follow‐up.
Among 76 patients (median age, 61 years), moderate‐to‐severe CIPN was observed less frequently in compression limbs than in control limbs at Cycle 3 (35.5% vs. 53.9%; p = 0.001), EOT (59.2% vs. 69.7%; p = 0.021), 3 months (28.9% vs. 52.6%; p = 0.015), and 6 months (20.3% vs. 33.8%; p = 0.002). Repeated‐measures analyzes showed significant time‐by‐limb interactions for sensory (p = 0.003), lower‐extremity sensory (p = 0.018), and motor domains (p = 0.041). Sensory CIPN20 scores were lower in compression limbs in the upper extremities from EOT onward (7.5 vs. 10.2; p < 0.001) and in the lower extremities at 3‐month (8.7 vs. 10.7; p < 0.001) and 6‐month follow‐up (7.0 vs. 10.0; p < 0.001).
EORTC QLQ‐CIPN20 sensory scores identified grade ≥ 2 neuropathy with AUC values > 0.92 at all time points. Dual‐site mechanical compression was associated with reduced incidence and persistence of CIPN. As a low‐cost and scalable intervention, this strategy may improve treatment tolerability and survivorship outcomes.
Trial Registration:
ClinicalTrials.gov identifier: NCT07105553
What's new?
With no effective drug‐based prevention strategies available for chemotherapy‐induced peripheral neuropathy (CIPN), research in neuroprotective approaches has grown. Of particular interest is mechanical compression, which may protect nerves by temporarily reducing blood flow during treatment. The authors here conducted a prospective trial in women with gynecologic cancers, applying mechanical compression to one hand and leg during treatment while using the opposite limbs as controls. Compression‐treated limbs consistently experienced lower rates and severity of neuropathy during treatment and up to six months afterward.
As a low‐cost, scalable intervention, dual‐site mechanical compression can potentially improve treatment tolerability and reduce long‐term nerve damage.
Publication and source details
Original title: Limb Compression Therapy and Chemotherapy‐Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self‐Controlled Study(NEURO‐GLOVE Trial)
Kadriye Başkurt; Galip Can Uyar; Enes Yeşilbaş; Fatma Zehra Altunç; Damla Erimhan Çevik; İsmet Murat Melek; Yasemin Eren; Ömür Berna Çakmak Öksüzoğlu; Kadriye Bir Yücel; Antonio Di Meglio; Isabelle Ray‐Coquard; Osman Sütcüoğlu
International Journal of Cancer · 2026
* Correspondence:Osman Sütcüoğlu (osmansutcuoglu@gazi.edu.tr)
© 2026 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:17:43.573632+00:00
DOI: 10.1002/ijc.70601 · PMC13547992